Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering

May 15, 2017 — Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics from the offering are approximately $79.3 million before deducting underwriting commissions and discounts, and estimated offering expenses payable by the company.

Continue reading

Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017

May 03, 2017 — Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the same period in the prior year.

Continue reading

Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd

Apr 18, 2017 — Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial results and commercial progress.

Continue reading

Fourth Quarter and Full Year 2016 Financial Results

Feb 28, 2017 — Accelerate Diagnostics filed Fourth Quarter and Full Year 2016 financial results today. Access them directly on our website in the SEC filings section of our Investors page or through the Securities and Exchange Commission’s (SEC) website.

Continue reading

See all news
Media kit
Media contact

Andy Chasteen

Company information

About the company
Our products

Digital assets

Enter your email address below for access to photos, logos and videos.

See Terms and Use Policy

Connect with us

  Like us on Facebook
  Follow us on Twitter
  See us on Linkedin
  Visit us on Google+

Upcoming Events
IDWeek 2017

October 4–8, 2017
San Diego

Learn more

Want to hear when we announce our next event?

Stay up to date with Accelerate by joining our mailing list.

Sign up today
Past Events
ASM Microbe 2017

June 1–5, 2017
New Orleans

Learn more

MAD-ID Annual Meeting

May 10–13, 2017
Orlando, FL

Learn more


April 22–25, 2017
Vienna, Austria

Learn more

CLMA 2017

March 26–28, 2017
Nashville, TN

Learn more


March 21–27, 2017
Brussels, Belgium

Learn more

Reanimation 2017

11 au 13 Janvier 2017
Porte de Versailles a Paris

Learn more

RICAI 2016

12-13 Décembre 2016
Palais des Congrès de Paris

Learn more

SEACM 2016

November 3-5, 2016
Atlanta, GA

Learn more

IDWeek 2016

October 26–30, 2016
New Orleans

Learn more

SWACM 2016

September 7–10, 2016
Fort Worth, TX

Learn more

ASM Microbe 2016

June 16–20, 2016

Learn more


April 9–12, 2016

Learn more

Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.

May 26, 2017

Automated microscopy for rapid directed antibiotic treatment of sepsis
M Kollef, C Burnham, B Fuller
Washington University School of Medicine

May 26, 2017

Evaluation of the Accelerate Pheno™ system for fast identification and antimicrobial susceptibility testing from positive blood culture in Gram-negative bloodstream infection
Matthias Marschal, Johanna Bachmaier, Ingo Autenrieth, Philipp Oberhettinger, Matthias Willmann and Silke Peter
University of Tübingen

May 22, 2017

Evaluation of Accelerate Pheno™ System in a Clinical Setting: Comparison of Identification and Antibiotic Susceptibility Test Results of 224 Prospective Positive Blood Cultures to Standard Laboratory Methods at Detroit Medical Center

May 22, 2017

Predicting the hVISA Phenotype Using a Novel in vitro Real-time Assessment of S. aureus Division Rates

See all publications

Get some


Learn about our